PURPOSE: Pediatric sarcomas provide a unique diagnostic challenge. There is considerable morphologic overlap between entities, increasing the importance of molecular studies in the diagnosis, treatment, and identification of therapeutic targets. We developed and validated a genome-wide DNA methylation based classifier to differentiate between osteosarcoma, Ewing's sarcoma, and synovial sarcoma. MATERIALS AND METHODS: DNA methylation status of 482,421 CpG sites in 10 Ewing's sarcoma, 11 synovial sarcoma, and 15 osteosarcoma samples were determined using the Illumina Infinium HumanMethylation450 array. We developed a random forest classifier trained from the 400 most differentially methylated CpG sites within the training set of 36 sarcoma samples. This classifier was validated on data drawn from The Cancer Genome Atlas (TCGA) synovial sarcoma, TARGET Osteosarcoma, and a recently published series of Ewing's sarcoma. RESULTS: Methylation profiling revealed three distinct patterns, each enriched with a single sarcoma subtype. Within the validation cohorts, all samples from TCGA were accurately classified as synovial sarcoma (10/10, sensitivity and specificity 100%), all but one sample from TARGET-OS were classified as osteosarcoma (85/86, sensitivity 98%, specificity 100%) and 14/15 Ewing's sarcoma samples classified correctly (sensitivity 93%, specificity 100%). The single misclassified osteosarcoma sample demonstrated high EWSR1 and ETV1 expression on RNA-seq although no fusion was found on manual curation of the transcript sequence. Two additional clinical samples, that were difficult to classify by morphology and molecular methods, were classified as osteosarcoma when previously suspected to be a synovial sarcoma and Ewing's sarcoma on initial diagnosis, respectively. CONCLUSION: Osteosarcoma, synovial sarcoma, and Ewing's sarcoma have distinct epigenetic profiles. Our validated methylation-based classifier can be used to provide diagnostic assistance when histological and standard techniques are inconclusive.
PURPOSE: Pediatric sarcomas provide a unique diagnostic challenge. There is considerable morphologic overlap between entities, increasing the importance of molecular studies in the diagnosis, treatment, and identification of therapeutic targets. We developed and validated a genome-wide DNA methylation based classifier to differentiate between osteosarcoma, Ewing's sarcoma, and synovial sarcoma. MATERIALS AND METHODS: DNA methylation status of 482,421 CpG sites in 10 Ewing's sarcoma, 11 synovial sarcoma, and 15 osteosarcoma samples were determined using the Illumina Infinium HumanMethylation450 array. We developed a random forest classifier trained from the 400 most differentially methylated CpG sites within the training set of 36 sarcoma samples. This classifier was validated on data drawn from The Cancer Genome Atlas (TCGA) synovial sarcoma, TARGET Osteosarcoma, and a recently published series of Ewing's sarcoma. RESULTS: Methylation profiling revealed three distinct patterns, each enriched with a single sarcoma subtype. Within the validation cohorts, all samples from TCGA were accurately classified as synovial sarcoma (10/10, sensitivity and specificity 100%), all but one sample from TARGET-OS were classified as osteosarcoma (85/86, sensitivity 98%, specificity 100%) and 14/15 Ewing's sarcoma samples classified correctly (sensitivity 93%, specificity 100%). The single misclassified osteosarcoma sample demonstrated high EWSR1 and ETV1 expression on RNA-seq although no fusion was found on manual curation of the transcript sequence. Two additional clinical samples, that were difficult to classify by morphology and molecular methods, were classified as osteosarcoma when previously suspected to be a synovial sarcoma and Ewing's sarcoma on initial diagnosis, respectively. CONCLUSION: Osteosarcoma, synovial sarcoma, and Ewing's sarcoma have distinct epigenetic profiles. Our validated methylation-based classifier can be used to provide diagnostic assistance when histological and standard techniques are inconclusive.
Authors: Ema Dragoescu; Colleen Jackson-Cook; Gregory Domson; Davis Massey; William C Foster Journal: Ann Diagn Pathol Date: 2012-09-10 Impact factor: 2.090
Authors: Jan Smida; Daniel Baumhoer; Michael Rosemann; Axel Walch; Stefan Bielack; Christopher Poremba; Klaus Remberger; Eberhard Korsching; Wolfram Scheurlen; Christian Dierkes; Stefan Burdach; Gernot Jundt; Michael J Atkinson; Michaela Nathrath Journal: Clin Cancer Res Date: 2010-07-07 Impact factor: 12.531
Authors: Manuel Röhrich; Christian Koelsche; Daniel Schrimpf; David Capper; Felix Sahm; Annekathrin Kratz; Jana Reuss; Volker Hovestadt; David T W Jones; Melanie Bewerunge-Hudler; Albert Becker; Joachim Weis; Christian Mawrin; Michel Mittelbronn; Arie Perry; Victor-Felix Mautner; Gunhild Mechtersheimer; Christian Hartmann; Ali Fuat Okuducu; Mirko Arp; Marcel Seiz-Rosenhagen; Daniel Hänggi; Stefanie Heim; Werner Paulus; Jens Schittenhelm; Rezvan Ahmadi; Christel Herold-Mende; Andreas Unterberg; Stefan M Pfister; Andreas von Deimling; David E Reuss Journal: Acta Neuropathol Date: 2016-02-08 Impact factor: 17.088
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: M Schulte; D Brecht-Krauss; B Heymer; A Guhlmann; E Hartwig; M R Sarkar; C G Diederichs; A Von Baer; J Kotzerke; S N Reske Journal: J Nucl Med Date: 2000-10 Impact factor: 10.057
Authors: Y Kaneko; K Yoshida; M Handa; Y Toyoda; H Nishihira; Y Tanaka; Y Sasaki; S Ishida; F Higashino; K Fujinaga Journal: Genes Chromosomes Cancer Date: 1996-02 Impact factor: 5.006
Authors: Paul A Northcott; David J H Shih; Marc Remke; Yoon-Jae Cho; Marcel Kool; Cynthia Hawkins; Charles G Eberhart; Adrian Dubuc; Toumy Guettouche; Yoslayma Cardentey; Eric Bouffet; Scott L Pomeroy; Marco Marra; David Malkin; James T Rutka; Andrey Korshunov; Stefan Pfister; Michael D Taylor Journal: Acta Neuropathol Date: 2011-11-06 Impact factor: 17.088
Authors: Colleen M Costelloe; Hubert H Chuang; Beth A Chasen; Tinsu Pan; Patricia S Fox; Roland L Bassett; John E Madewell Journal: J Cancer Date: 2013-08-09 Impact factor: 4.207
Authors: Ruben Van Paemel; Andries De Koker; Charlotte Vandeputte; Lieke van Zogchel; Tim Lammens; Geneviève Laureys; Jo Vandesompele; Gudrun Schleiermacher; Mathieu Chicard; Nadine Van Roy; Ales Vicha; G A M Tytgat; Nico Callewaert; Katleen De Preter; Bram De Wilde Journal: Epigenetics Date: 2020-07-14 Impact factor: 4.528
Authors: Christian Koelsche; Daniel Schrimpf; Damian Stichel; Martin Sill; Felix Sahm; David E Reuss; Mirjam Blattner; Barbara Worst; Christoph E Heilig; Katja Beck; Peter Horak; Simon Kreutzfeldt; Elke Paff; Sebastian Stark; Pascal Johann; Florian Selt; Jonas Ecker; Dominik Sturm; Kristian W Pajtler; Annekathrin Reinhardt; Annika K Wefers; Philipp Sievers; Azadeh Ebrahimi; Abigail Suwala; Francisco Fernández-Klett; Belén Casalini; Andrey Korshunov; Volker Hovestadt; Felix K F Kommoss; Mark Kriegsmann; Matthias Schick; Melanie Bewerunge-Hudler; Till Milde; Olaf Witt; Andreas E Kulozik; Marcel Kool; Laura Romero-Pérez; Thomas G P Grünewald; Thomas Kirchner; Wolfgang Wick; Michael Platten; Andreas Unterberg; Matthias Uhl; Amir Abdollahi; Jürgen Debus; Burkhard Lehner; Christian Thomas; Martin Hasselblatt; Werner Paulus; Christian Hartmann; Ori Staszewski; Marco Prinz; Jürgen Hench; Stephan Frank; Yvonne M H Versleijen-Jonkers; Marije E Weidema; Thomas Mentzel; Klaus Griewank; Enrique de Álava; Juan Díaz Martín; Miguel A Idoate Gastearena; Kenneth Tou-En Chang; Sharon Yin Yee Low; Adrian Cuevas-Bourdier; Michel Mittelbronn; Martin Mynarek; Stefan Rutkowski; Ulrich Schüller; Viktor F Mautner; Jens Schittenhelm; Jonathan Serrano; Matija Snuderl; Reinhard Büttner; Thomas Klingebiel; Rolf Buslei; Manfred Gessler; Pieter Wesseling; Winand N M Dinjens; Sebastian Brandner; Zane Jaunmuktane; Iben Lyskjær; Peter Schirmacher; Albrecht Stenzinger; Benedikt Brors; Hanno Glimm; Christoph Heining; Oscar M Tirado; Miguel Sáinz-Jaspeado; Jaume Mora; Javier Alonso; Xavier Garcia Del Muro; Sebastian Moran; Manel Esteller; Jamal K Benhamida; Marc Ladanyi; Eva Wardelmann; Cristina Antonescu; Adrienne Flanagan; Uta Dirksen; Peter Hohenberger; Daniel Baumhoer; Wolfgang Hartmann; Christian Vokuhl; Uta Flucke; Iver Petersen; Gunhild Mechtersheimer; David Capper; David T W Jones; Stefan Fröhling; Stefan M Pfister; Andreas von Deimling Journal: Nat Commun Date: 2021-01-21 Impact factor: 17.694
Authors: Benjamin A Nacev; Kevin B Jones; Andrew M Intlekofer; Jamie S E Yu; C David Allis; William D Tap; Marc Ladanyi; Torsten O Nielsen Journal: Nat Rev Cancer Date: 2020-08-11 Impact factor: 69.800